author_facet Xu, Yong Zhong
Heravi, Mitra
Thuraisingam, Thusanth
Marco, Sergio Di
Muanza, Thierry
Radzioch, Danuta
Xu, Yong Zhong
Heravi, Mitra
Thuraisingam, Thusanth
Marco, Sergio Di
Muanza, Thierry
Radzioch, Danuta
author Xu, Yong Zhong
Heravi, Mitra
Thuraisingam, Thusanth
Marco, Sergio Di
Muanza, Thierry
Radzioch, Danuta
spellingShingle Xu, Yong Zhong
Heravi, Mitra
Thuraisingam, Thusanth
Marco, Sergio Di
Muanza, Thierry
Radzioch, Danuta
Molecular Cancer
Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
Cancer Research
Oncology
Molecular Medicine
author_sort xu, yong zhong
spelling Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta 1476-4598 Springer Science and Business Media LLC Cancer Research Oncology Molecular Medicine http://dx.doi.org/10.1186/1476-4598-9-210 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec> Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 Molecular Cancer
doi_str_mv 10.1186/1476-4598-9-210
facet_avail Online
Free
finc_class_facet Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc2LTQ1OTgtOS0yMTA
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc2LTQ1OTgtOS0yMTA
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint Springer Science and Business Media LLC, 2010
imprint_str_mv Springer Science and Business Media LLC, 2010
issn 1476-4598
issn_str_mv 1476-4598
language English
mega_collection Springer Science and Business Media LLC (CrossRef)
match_str xu2010brg1mediatestheconstitutiveandfenretinideinducedexpressionofsparcinmammarycarcinomacellsviaitsinteractionwithtranscriptionfactorsp1
publishDateSort 2010
publisher Springer Science and Business Media LLC
recordtype ai
record_format ai
series Molecular Cancer
source_id 49
title Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_unstemmed Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_full Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_fullStr Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_full_unstemmed Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_short Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_sort brg-1 mediates the constitutive and fenretinide-induced expression of sparc in mammary carcinoma cells via its interaction with transcription factor sp1
topic Cancer Research
Oncology
Molecular Medicine
url http://dx.doi.org/10.1186/1476-4598-9-210
publishDate 2010
physical
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec>
container_issue 1
container_start_page 0
container_title Molecular Cancer
container_volume 9
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792340282027540488
geogr_code not assigned
last_indexed 2024-03-01T16:01:08.018Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Brg-1+mediates+the+constitutive+and+fenretinide-induced+expression+of+SPARC+in+mammary+carcinoma+cells+via+its+interaction+with+transcription+factor+Sp1&rft.date=2010-12-01&genre=article&issn=1476-4598&volume=9&issue=1&jtitle=Molecular+Cancer&atitle=Brg-1+mediates+the+constitutive+and+fenretinide-induced+expression+of+SPARC+in+mammary+carcinoma+cells+via+its+interaction+with+transcription+factor+Sp1&aulast=Radzioch&aufirst=Danuta&rft_id=info%3Adoi%2F10.1186%2F1476-4598-9-210&rft.language%5B0%5D=eng
SOLR
_version_ 1792340282027540488
author Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta
author_facet Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta, Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta
author_sort xu, yong zhong
container_issue 1
container_start_page 0
container_title Molecular Cancer
container_volume 9
description <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec>
doi_str_mv 10.1186/1476-4598-9-210
facet_avail Online, Free
finc_class_facet Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE4Ni8xNDc2LTQ1OTgtOS0yMTA
imprint Springer Science and Business Media LLC, 2010
imprint_str_mv Springer Science and Business Media LLC, 2010
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 1476-4598
issn_str_mv 1476-4598
language English
last_indexed 2024-03-01T16:01:08.018Z
match_str xu2010brg1mediatestheconstitutiveandfenretinideinducedexpressionofsparcinmammarycarcinomacellsviaitsinteractionwithtranscriptionfactorsp1
mega_collection Springer Science and Business Media LLC (CrossRef)
physical
publishDate 2010
publishDateSort 2010
publisher Springer Science and Business Media LLC
record_format ai
recordtype ai
series Molecular Cancer
source_id 49
spelling Xu, Yong Zhong Heravi, Mitra Thuraisingam, Thusanth Marco, Sergio Di Muanza, Thierry Radzioch, Danuta 1476-4598 Springer Science and Business Media LLC Cancer Research Oncology Molecular Medicine http://dx.doi.org/10.1186/1476-4598-9-210 <jats:title>Abstract</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Secreted protein, acidic and rich in cysteine (SPARC) is a matricellular protein that mediates cell-matrix interactions. It has been shown, depending on the type of cancer, to possess either pro- or anti-tumorigenic properties. The transcriptional regulation of the SPARC gene expression has not been fully elucidated and the effects of anti-cancer drugs on this process have not been explored.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>In the present study, we demonstrated that chromatin remodeling factor Brg-1 is recruited to the proximal SPARC promoter region (-130/-56) through an interaction with transcription factor Sp1. We identified Brg-1 as a critical regulator for the constitutive expression levels of SPARC mRNA and protein in mammary carcinoma cell lines and for SPARC secretion into culture media. Furthermore, we found that Brg-1 cooperates with Sp1 to enhance SPARC promoter activity. Interestingly, fenretinide [N-4(hydroxyphenyl) retinamide, 4-HPR], a synthetic retinoid with anti-cancer properties, was found to up-regulate the transcription, expression and secretion of SPARC via induction of the Brg-1 in a dose-dependent manner. Finally, our results demonstrated that fenretinide-induced expression of SPARC contributes significantly to a decreased invasion of mammary carcinoma cells.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>Overall, our results reveal a novel cooperative role of Brg-1 and Sp1 in mediating the constitutive and fenretinide-induced expression of SPARC, and provide new insights for the understanding of the anti-cancer effects of fenretinide.</jats:p></jats:sec> Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1 Molecular Cancer
spellingShingle Xu, Yong Zhong, Heravi, Mitra, Thuraisingam, Thusanth, Marco, Sergio Di, Muanza, Thierry, Radzioch, Danuta, Molecular Cancer, Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1, Cancer Research, Oncology, Molecular Medicine
title Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_full Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_fullStr Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_full_unstemmed Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_short Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
title_sort brg-1 mediates the constitutive and fenretinide-induced expression of sparc in mammary carcinoma cells via its interaction with transcription factor sp1
title_unstemmed Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
topic Cancer Research, Oncology, Molecular Medicine
url http://dx.doi.org/10.1186/1476-4598-9-210